glp-1 vs gip Science Behind GLP 1 and Glucagon Receptor Agonists for Obesity Research | News & Announcements GLP-1 vs. GLP-1 + GIP:
Description
The real problem seems to be retention
Some employers choose to exclude GLP-1 drugs from employer-sponsored health plans
95% CI 0.89, 0.96) and all-cause mortality rate (HR 0.70
Called Foundayo, the tablet becomes the second one to receive FDAs green light after Novo Nordisks Wegovy
Regarding renal effects, the evidence of SGLT2is in preventing kidney failure is more abundant than for GLP-1RAs, which showed a beneficial effect on albuminuria but not on hard kidney endpoints
